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Background
Lynch syndrome is associated with mismatch repair
(MMR) gene mutations and high risk for early onset
colorectal (mean age 44 yr), endometrial (46), ovarian
(43), and stomach (56) cancers. The NCCN guidelines
recommend colonoscopy in unaffected individuals with
Lynch syndrome beginning at age 20-25 or ten years
earlier than the youngest diagnosis in the family.
Genetic testing is usually recommended just prior to the
initiation of screening and not before age 18. Despite
the reported mean ages, we often observe an outlier—an
individual diagnosed with cancer much earlier than
others in the family—which challenges our conventional
wisdom and advice for the whole family. The purpose of
this study was to explore how often this occurs, the size
of age gap between the youngest diagnosis and the sec-
ond youngest, and how these diagnoses may impact
recommendations for other family members.
Methods
Full pedigrees of participants with MMR mutations from
an IRB-approved hereditary cancer registry were ana-
lyzed with special attention to age of cancer diagnosis
and degree of relationship to the consultant. Cancer
diagnoses included in analysis were those for which
there are management recommendations (colorectal,
endometrial, ovarian, gastric, small bowel).
Results
Fifty-two Lynch syndrome families were identified; in 24
(46.2%), the earliest diagnosis was <35 and in 3 (5.8%)
the earliest diagnosis was <28. Forty-eight had more
than one individual with a Lynch-related tumor, and of
those, 15 (31.3%) had an age gap of ≥10 years between
the youngest diagnosis and second youngest diagnosis
which would potentially impact recommendations for
earliest age to test and screen. The average age gap
overall was 7.3 years.
Conclusions
These data represent a clinical conundrum for those
who provide genetic cancer risk assessment. Many clini-
cians may be inclined to provide reassurance to Lynch
families whose cancer diagnoses are later in age. How-
ever, our results suggest adherence to the guideline
recommending relatively early age for initiation of test-
ing and screening given that 31.3% of families in our
sample had an individual diagnosed ≥10 years before the
next youngest diagnosis. Conversely, “the ten year rule”
would cause 46% of families in our sample to begin
screening before age 25 even if most others in the family
were diagnosed after 40, and would invoke screening as
well as genetic testing prior to age 18 in 5.8% of
families. More research must be done to elucidate
causes of variable expressivity in this syndrome.
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